Overview Dividends

(XRX) Xerox - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98421M1062

Printers, Copiers, Software, Services, Financing

Technology Hardware, Storage & Peripherals
Market Cap in USD: 334m

IPO / Inception: 1977-01-03
Return 12m vs S&P 500: -72.1%

EPS (Earnings per Share)

EPS CAGR: -13.19%
EPS Trend: -33.2%

Last SUE: 1.56
Qual. Beats: 1

Revenue

Rev. CAGR: 2.66%
Rev. Trend: -37.4%

Last SUE: -1.62
Qual. Beats: 0

Dividends

Dividend Yield	17.18%
Yield on Cost 5y	2.73%
Yield CAGR 5y	0.00%
Payout Consistency	81.3%
Payout Ratio	94.3%

Risk via 5d forecast
Volatility	73.5%
Value at Risk 5%th	103%
Relative Tail Risk	-14.76%

Reward TTM
Sharpe Ratio	-1.30
Alpha	-88.16
CAGR/Max DD	-0.46

Character TTM
Hurst Exponent	0.505
Beta	1.683
Beta Downside	1.350

Drawdowns 3y
Max DD	86.50%
Mean DD	37.43%
Median DD	33.66%

Description: XRX Xerox October 22, 2025

Xerox Holdings Corp. (NASDAQ:XRX) is a global workplace-technology firm that blends hardware, software, and services across two segments-Print & Other and Xerox Financial Services (XFS). Its portfolio spans entry-level A4 printers, mid-range A3 devices, ConnectKey software, production presses, Managed Print Services, IT solutions, and financing options for both direct and indirect channel customers.

Key recent metrics: FY 2023 revenue was approximately $9.3 billion, with services and solutions contributing roughly 45 % of that total and growing at a 6 % YoY rate, while traditional print hardware declined about 4 % amid corporate cost-cutting and a broader shift toward digital document workflows. The company’s operating margin improved to 6.8 % after a restructuring that emphasized recurring-revenue models, and its free-cash-flow conversion hovered near 55 %-a notable outperformance versus the average 40 % seen in the broader technology-hardware sector. Macro-level drivers include sustained enterprise spending on automation, rising interest-rate sensitivity that can affect XFS financing demand, and supply-chain pressures that favor vendors with diversified component sourcing.

For a deeper quantitative dive, the ValueRay platform offers a granular breakdown of XRX’s cash-flow trends and peer-adjusted multiples.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-977.0m TTM) > 0 and > 6% of Revenue (6% = 396.4m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA -2.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 5.36% (prev 9.70%; Δ -4.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.04 (>3.0%) and CFO 410.0m > Net Income -977.0m (YES >=105%, WARN >=100%)

Net Debt (3.93b) to EBITDA (89.0m) ratio: 44.12 <= 3.0 (WARN <= 3.5)

Current Ratio 1.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (125.8m) change vs 12m ago 1.16% (target <= -2.0% for YES)

Gross Margin 38.47% (prev 32.17%; Δ 6.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 71.85% (prev 76.58%; Δ -4.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -1.17 (EBITDA TTM 89.0m / Interest Expense TTM 199.0m) >= 6 (WARN >= 3)

Altman Z'' 0.79

(A) 0.04 = (Total Current Assets 3.75b - Total Current Liabilities 3.40b) / Total Assets 10.07b

(B) 0.25 = Retained Earnings (Balance) 2.52b / Total Assets 10.07b

(D) -0.09 = Book Value of Equity -806.0m / Total Liabilities 9.47b

Total Rating: 0.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 35.33

1. Piotroski 3.0pt

2. FCF Yield 7.65%

3. FCF Margin 4.93%

4. Debt/Equity 7.61

5. Debt/Ebitda 44.12

6. ROIC - WACC (= -4.61)%

7. RoE -87.39%

8. Rev. Trend -37.39%

9. EPS Trend -33.16%

What is the price of XRX shares?

As of December 21, 2025, the stock is trading at USD 2.62 with a total of 4,686,227 shares traded.
Over the past week, the price has changed by +0.38%, over one month by +6.94%, over three months by -35.67% and over the past year by -67.20%.

Is XRX a buy, sell or hold?

Xerox has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold XRX.

Strong Buy: 1
Buy: 0
Hold: 2
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the XRX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	3.8	43.1%
Analysts Target Price	3.8	43.1%
ValueRay Target Price	2	-22.5%

XRX Fundamental Data Overview December 16, 2025

Market Cap USD = 334.2m (334.2m USD * 1.0 USD.USD)
P/E Forward = 2.6069
P/S = 0.0506
P/B = 0.9156
P/EG = 0.1984
Beta = 1.753
Revenue TTM = 6.61b USD
EBIT TTM = -232.0m USD
EBITDA TTM = 89.0m USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 354.0m USD (from shortTermDebt, last quarter)
Debt = 4.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.93b USD (from netDebt column, last quarter)
Enterprise Value = 4.26b USD (334.2m + Debt 4.41b - CCE 479.0m)
Interest Coverage Ratio = -1.17 (Ebit TTM -232.0m / Interest Expense TTM 199.0m)
FCF Yield = 7.65% (FCF TTM 326.0m / Enterprise Value 4.26b)
FCF Margin = 4.93% (FCF TTM 326.0m / Revenue TTM 6.61b)
Net Margin = -14.79% (Net Income TTM -977.0m / Revenue TTM 6.61b)
Gross Margin = 38.47% ((Revenue TTM 6.61b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 59.82% (prev 27.98%)
Tobins Q-Ratio = 0.42 (Enterprise Value 4.26b / Total Assets 10.07b)
Interest Expense / Debt = 1.82% (Interest Expense 80.0m / Debt 4.41b)
Taxrate = -153.3% (out of range, set to none) (460.0m / -300.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.10 (Total Current Assets 3.75b / Total Current Liabilities 3.40b)
Debt / Equity = 7.61 (Debt 4.41b / totalStockholderEquity, last quarter 579.0m)
Debt / EBITDA = 44.12 (Net Debt 3.93b / EBITDA 89.0m)
Debt / FCF = 12.05 (Net Debt 3.93b / FCF TTM 326.0m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.70% (Net Income -977.0m / Total Assets 10.07b)
RoE = -87.39% (Net Income TTM -977.0m / Total Stockholder Equity 1.12b)
RoCE = -4.49% (EBIT -232.0m / Capital Employed (Equity 1.12b + L.T.Debt 4.05b))
RoIC = -3.75% (negative operating profit) (EBIT -232.0m / (Assets 10.07b - Curr.Liab 3.40b - Cash 479.0m))
WACC = 0.86% (E(334.2m)/V(4.74b) * Re(12.22%) + (debt cost/tax rate unavailable))
Discount Rate = 12.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.10%
[DCF Debug] Terminal Value 65.31% ; FCFE base≈400.4m ; Y1≈415.9m ; Y5≈476.2m
Fair Price DCF = 35.75 (DCF Value 4.58b / Shares Outstanding 128.0m; 5y FCF grow 4.06% → 3.0% )
EPS Correlation: -33.16 | EPS CAGR: -13.19% | SUE: 1.56 | # QB: 1
Revenue Correlation: -37.39 | Revenue CAGR: 2.66% | SUE: -1.62 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=-0.270 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.07 | Chg30d=-0.461 | Revisions Net=+0 | Growth EPS=+373.4% | Growth Revenue=+12.1%

Additional Sources for XRX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle